Financials in USD. Standardized financial statements.
A compact view of how Genetic Technologies Limited turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $7.66M | $10.35M | $6.79M | $120,554 | $837,865 | $25,444 | $189,254 | $518,506 | $824,586 | $2.01M |
| Revenue Growth? | -25.9% | +52.3% | +5536.3% | -85.6% | +3193.0% | -86.6% | -63.5% | -37.1% | -59.0% | 0.0% |
| Cost of Revenue? | $3.76M | $4.34M | $321,223 | $361,027 | $101,433 | $276,267 | $300,088 | $492,417 | $743,060 | $1.33M |
| Gross Profit? | $3.90M | $6.01M | $6.47M | -$240,473 | $736,432 | -$250,823 | -$110,834 | $26,089 | $81,526 | $685,257 |
| Gross Margin? | +50.9% | +58.1% | +95.3% | -199.5% | +87.9% | -985.8% | -58.6% | +5.0% | +9.9% | +34.1% |
| Operating Expenses? | $16.11M | $18.11M | $3.11M | $7.00M | $6.98M | $6.18M | $5.34M | $8.44M | $8.58M | $9.27M |
| Operating Income? | -$12.21M | -$10.42M | -$7.54M | -$7.42M | -$5.94M | -$7.02M | -$6.40M | -$8.17M | -$8.49M | -$9.87M |
| EBITDA? | -$11.43M | -$11.20M | -$7.20M | -$6.58M | -$5.87M | -$6.25M | -$5.46M | -$7.80M | -$8.10M | -$8.42M |
| Income Before Tax | -$12.02M | -$11.91M | -$7.16M | -$7.08M | -$6.29M | -$6.43M | -$5.46M | -$8.40M | -$8.46M | -$8.81M |
| Income Tax Expense | $0 | -$158,329 | -$32,125 | $0 | $0 | $0 | $0 | $0 | -$359,803 | $0 |
| Net Income? | -$12.02M | -$11.75M | -$7.13M | -$7.08M | -$6.29M | -$6.43M | -$5.46M | -$8.40M | -$8.46M | -$8.81M |
| EPS? | $-2.73 | $-3.60 | $-2.32 | $-2.48 | $-4.50 | $-6.90 | $-6.60 | $-12.00 | $-14.70 | $-24.60 |
| Diluted EPS? | $-2.73 | $-3.60 | $-2.32 | $-2.48 | $-4.50 | $-6.90 | $-6.60 | $-12.00 | $-14.70 | $-24.60 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality